Semax 20 mg
SKU
AZ-NS-SEMAX-20

Semax 20 mg

Pricing

In stock

Fulfillment Timing Based on Inventory and Account Status.

Semax 20 mg
HPLC Certified
CAS #
80714-61-0
M.W.
813.93
Formula
C37H51N9O10S
RUO
Specs:

What Is Semax 20 mg Research Solution?

Semax is a synthetic heptapeptide with the amino-acid sequence Met-Glu-His-Phe-Pro-Gly-Pro. This page is drafted for the non-acetylated Semax research material; the finished-product identity should be confirmed against the applicable Certificate of Analysis before publication.

This product is supplied as a 15 mL research solution in a blue glass bottle fitted with a metered atomizer assembly. The nominal bottle content is 20 mg Semax. Based on an approximate device yield of 150 actuations, the calculated nominal amount is approximately 133 µg per actuation. This calculated value is a laboratory device parameter only; actual delivered volume and material per actuation should be verified experimentally for the specific lot and device configuration.

Semax Research Material Overview

  • Compound class: synthetic heptapeptide research material
  • Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
  • Nominal amount: 20 mg per 15 mL bottle
  • Format: aqueous research solution
  • Container: blue glass bottle with metered atomizer assembly
  • Approximate device yield: 150 actuations per bottle
  • Nominal calculated amount per actuation: approximately 133 µg
  • Analytical focus: peptide identity, purity, sequence-related characterization, solution stability, and metered-dispensing consistency

Batch-specific identity, purity, concentration, and other analytical results should be confirmed against the applicable Certificate of Analysis and lot documentation. Storage conditions should follow the validated lot-specific product documentation for the finished solution.

Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, consumption, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.

Semax 20 mg Research Applications

Semax 20 mg Research Solution is intended for controlled laboratory and analytical investigation of peptide identity, solution characteristics, material stability, and metered-dispensing performance.

Peptide Identity and Molecular Characterization

Semax may be evaluated using validated LC-MS, mass-spectrometric, chromatographic, and peptide-mapping methods to confirm molecular identity and expected sequence-related characteristics.

Purity and Related-Substance Profiling

HPLC, UPLC, and complementary analytical methods may be used to assess peptide purity, related substances, degradation products, and lot-specific quality characteristics.

Solution Stability Research

Researchers may evaluate the finished research solution under defined laboratory conditions to characterize peptide integrity, degradation patterns, and concentration stability over time.

Metered-Dispensing and Container-Closure Studies

The finished configuration may be evaluated for actuation-to-actuation consistency, nominal delivered volume, solution homogeneity, and compatibility with the bottle and atomizer components.

Comparative and Batch-Consistency Analysis

Semax research material may be compared across reference standards or independently manufactured lots for identity, purity, concentration, chromatographic behavior, and finished-device performance.

Experimental design, analytical methodology, and laboratory conditions should be determined by qualified researchers according to validated procedures and study objectives.

Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, consumption, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.

Research Summary: Semax Analytical and Finished-Solution Characterization

Semax 20 mg Research Solution is supplied for controlled analytical characterization, quality assessment, stability research, and metered-device performance testing.

Research AreaAnalytical ApproachResearch Objective
Peptide IdentityLC-MS, mass spectrometry, or validated peptide identity methodsConfirm expected molecular identity and peptide characteristics.
Sequence-Related CharacterizationPeptide mapping and fragmentation analysisEvaluate sequence-associated analytical features.
Purity AssessmentHPLC/UPLC and complementary methodsEvaluate purity and detect related substances or degradation products.
Solution StabilityControlled comparative stability testingAssess peptide integrity and concentration under defined laboratory conditions.
Metered-Dispensing UniformityGravimetric, volumetric, or validated device testingEvaluate actuation consistency and nominal delivered amount.
Container CompatibilityComparative analytical testingAssess finished-solution compatibility with the bottle and atomizer assembly.
Batch ConsistencyLot-specific analytical comparisonCompare identity, purity, concentration, and device-performance characteristics across lots.

Batch-specific analytical results should be reviewed through the applicable Certificate of Analysis and supporting quality-control documentation.

Research Use Only. This material is intended solely for controlled laboratory, analytical, and scientific research. It is not for human or veterinary use or administration, consumption, diagnosis, treatment, prevention, cosmetic use, food use, or personal use.

Research use only

All AZOTH products are intended solely for laboratory research, analytical, and scientific use. Products are not for human consumption, human use, veterinary use, diagnostic use, therapeutic use, or administration of any kind.